Look beyond the Heart: Extracoronary Vascular Manifestations of Spontaneous Coronary Artery Dissection

References

1. 1.↵
   2. Hayes SN,
   3. Kim ES,
   4. Saw J, et al

   . American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; and Stroke Council. Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association. Circulation 2018;137:e523–57 doi:10.1161/CIR.0000000000000564 pmid:29472380

   Abstract/FREE Full Text
2. 2.↵
   2. Benson JC,
   3. Lehman VT,
   4. Verdoorn JT, et al

   . Prevalence of cervical artery abnormalities on CTA in patients with spontaneous coronary artery dissection: fibromuscular dysplasia, dissection, aneurysm, and tortuosity. AJNR Am J Neuroradiol 2021 May 13. [Epub ahead of print]. doi:10.3174/ajnr.A7151 pmid:33985951

   CrossRefPubMed
3. 3.↵
   2. McNair PW,
   3. Parker A,
   4. Taylor A, et al

   . Spontaneous coronary artery dissection and its association with fibromuscular dysplasia and other vascular abnormalities. Am J Cardiol 2020;125:34–39 doi:10.1016/j.amjcard.2019.09.043 pmid:31706452

   CrossRefPubMed
4. 4.↵
   2. Saw J,
   3. Starovoytov A,
   4. Humphries K, et al

   . Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes. Eur Heart J 2019;40:1188–97 doi:10.1093/eurheartj/ehz007 pmid:30698711

   CrossRefPubMed
5. 5.↵
   2. Kim ES

   . Spontaneous coronary-artery dissection. N Engl J Med 2020;383:2358–70 doi:10.1056/NEJMra2001524 pmid:33296561

   CrossRefPubMed
6. 6.↵
   2. Gornik HL,
   3. Persu A,
   4. Adlam D, et al

   . First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med 2019;24:164–89 doi:10.1177/1358863X18821816 pmid:30648921

   CrossRefPubMed
7. 7.↵
   2. Saw J,
   3. Humphries K,
   4. Aymong E, et al

   . Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence. J Am Coll Cardiol 2017;70:1148–45 doi:10.1016/j.jacc.2017.06.053 pmid:28838364

   FREE Full Text
8. 8.↵
   2. Lather HD,
   3. Gornik HL,
   4. Olin JW, et al

   . Prevalence of intracranial aneurysm in women with fibromuscular dysplasia: a report from the US Registry for Fibromuscular Dysplasia. JAMA Neurol 2017;74:1081–87 doi:10.1001/jamaneurol.2017.1333 pmid:28715558

   CrossRefPubMed
9. 9.↵
   2. Touzé E,
   3. Southerland AM,
   4. Boulanger M, et al

   . Fibromuscular dysplasia and its neurologic manifestations: a systematic review. JAMA Neurol 2019;76:217–26 doi:10.1001/jamaneurol.2018.2848 pmid:30285053

   CrossRefPubMed
10. 10.↵
    2. Prasad M,
    3. Tweet MS,
    4. Hayes SN, et al

    . Prevalence of extracoronary vascular abnormalities and fibromuscular dysplasia in patients with spontaneous coronary artery dissection. Am J Cardiol 2015;115:1672–77 doi:10.1016/j.amjcard.2015.03.011 pmid:25929580

    CrossRefPubMed
11. 11.↵
    2. Warchol-Celinska E,
    3. Berrandou T,
    4. Prejbisz A, et al

    . Genetic study of PHACTR1 and fibromuscular dysplasia, meta-analysis and effects on clinical features of patients: the ARCADIA-POL study. Hypertension 2020;76:e4–e7 doi:10.1161/HYPERTENSIONAHA.120.14793 pmid:32475314

    CrossRefPubMed
12. 12.↵
    2. Adlam D,
    3. Olson TM,
    4. Combaret N, et al

    . CARDIoGRAMPlusC4D Study Group. Association of the PHACTR1/EDN1 genetic locus with spontaneous coronary artery dissection. J Am Coll Cardiol 2019;73:58–66 doi:10.1016/j.jacc.2018.09.085 pmid:30621952

    FREE Full Text